Ivuxolimab is an OX40 (also known as CD134, TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4+ and CD8+ T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity.
CAS Number:
[2128729-41-7]
Target:
TNF Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
